MGI
AZN icon

Miller Global Investments’s AstraZeneca AZN Stock Holding History

Miller Global Investments’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$703K Buy
+3,706
New +$697K 0.58% 56
2026
Q1 		– Sell
-3,858
Closed -$709K – 281
2025
Q4 		$709K Buy
+3,858
New +$677K 0.64% 49

Other funds holding AZN

Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
RG
Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return
SAM
SEB Asset Management Stockholm $26.6B AUM
CDDEC
Caisse Des Depots Et Consignations Paris, France $5.91B AUM 35.65% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Miller Global Investments's AZN Position: Q2 2026 in Review

Miller Global Investments opened a new position in AstraZeneca (AZN) in Q2 2026: 3,706 shares worth $703K. The stake represents 0.58% of the portfolio and ranks #56 among its holdings. This is a return to the name: Miller Global Investments previously reported a position in AZN as recently as Q4 2025.

Miller Global Investments first reported a position in AZN in Q4 2025 and has held it in 2 quarters since. The position peaked at $709K in Q4 2025. 801 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • Miller Global Investments held 3,706 shares of AstraZeneca worth $703K as of Q2 2026.
  • AstraZeneca was a new Miller Global Investments position in Q2 2026.
  • AstraZeneca made up 0.58% of Miller Global Investments's portfolio in Q2 2026, its #56 holding.
  • Miller Global Investments first reported a position in AstraZeneca in Q4 2025 and has held it in 2 quarters since.
  • Miller Global Investments's AstraZeneca position peaked at $709K in Q4 2025.
  • 801 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Miller Global Investments's 13F filing for Q2 2026, filed 1 Jul 2026.